Audit preparation
Finding problems before an inspector does is far cheaper than responding to them after.
Models can continuously scan clinical data, manufacturing records, and lab results for the
kinds of anomalies that tend to surface during audits — turning reactive scrambles into
proactive catches.
Internal
AI as a compliance asset
Commercial
What to get right from the start
Intended use defines your regulatory path
A model used internally to flag potential issues for human review sits in a fundamentally
different risk tier than one that directly informs a clinical decision or diagnostic output.
That distinction determines which regulatory frameworks apply, how the model needs to
be validated, and what documentation is required.
Build in modules 
When an AI product is built in modular components, regulators can review each piece
independently rather than treating the entire system as a single submission. That means
when your model needs an update — and it will — you're resubmitting one component,
not your entire product.
Corrective action tracking
When an issue is flagged and resolved, how do you know it won't recur? Models can
connect new incidents to historical corrective actions and surface early warning signs of
recurring problems, which is nearly impossible to catch manually at scale.
Trial deviation monitoring
In clinical trials, catching a protocol deviation weeks after the fact is costly. AI can monitor
site data submissions in near real-time and flag deviations as they occur, reducing
expensive amendments and protecting data integrity before it's compromised.
Your data governance foundation determines everything else
You need to establish clear data lineage — knowing exactly where your training data came
from, how it was collected, whether it was appropriately de-identified, and whether it was
gathered under consent frameworks that cover this use.
24

View this content as a flipbook by clicking here.